ConforMIS News

Press Releases

  • Wednesday, 7/6/16

    Study Finds High Satisfaction Amongst Patients with ConforMIS Customized Total Knee Replacements

    iTotal-CR-502x301

    New data corroborates previous study that demonstrated higher satisfaction with iTotal CR than traditional, off-the-shelf implants Bedford, Mass. – July 6, 2016 – ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient’s unique anatomy, announced today…

    Read more »
  • Tuesday, 6/21/16

    ConforMIS iTotal® PS Customized Knee Replacement Honored as 2016 Gold Stevie® Award Winner

    ConforMIS Stevie Award

    Accolade recognizes innovation in first-ever customized posterior-stabilized total knee replacement system Bedford, Mass. – June 21, 2016 – ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced that their newest product to market, the iTotal® PS posterior-stabilized total knee replacement system, was named the winner…

    Read more »
  • Wednesday, 3/30/16

    ConforMIS Announces Positive Results from Clinical Studies Comparing the ConforMIS iTotal® CR to Leading “Off-The-Shelf” Total Knee Replacement Products

    ConforMIS customized knee replacement

    Multiple studies presented at BASK Annual Meeting support improved patient outcomes with ConforMIS customized total and partial knee replacements Bedford, Mass. – March 30, 2016 – ConforMIS, Inc., a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced results from multiple clinical studies scheduled to be presented at the 2016…

    Read more »
  • Wednesday, 3/2/16

    ConforMIS Announces Full Commercial Launch of iTotal® PS, the Only Customized Posterior Stabilized Total Knee Replacement System

    iTotal_PS_posterior view_502x301

    iTotal PS nearly triples the available market for ConforMIS Bedford, Mass. – March 2, 2016 – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient’s unique anatomy, today announced the full commercial launch of iTotal® PS, the…

    Read more »
  • Monday, 8/3/15

    ConforMIS Announces Results of Multiple Studies of its Customized Knee Replacements Presented at the 2015 Pan Pacific International Congress for Joint Reconstruction

    ConforMIS customized knee replacement

    ConforMIS’s customized iTotal CR knee replacements demonstrate superior functional outcomes compared to off-the-shelf knee replacements in multiple studies Bedford, Mass. – August 3, 2015 – ConforMIS, Inc. (NASDAQ: CFMS) announced today results from six clinical studies presented at the 2015 Pan Pacific International Congress for Joint Reconstruction (ICJR). In an ongoing, blinded, US multicenter study, the investigators reported…

    Read more »
  • Tuesday, 7/7/15

    ConforMIS Closes Initial Public Offering

    ConforMIS customized knee replacement

    Bedford, Mass. – July 7, 2015 – ConforMIS, Inc. (NASDAQ: CFMS) announced today the closing of its initial public offering of 10,350,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts, including 1,350,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase…

    Read more »
  • Wednesday, 7/1/15

    ConforMIS Announces Pricing of Its Initial Public Offering

    ConforMIS customized knee replacement

    Bedford, Mass. – June 30, 2015 – ConforMIS, Inc. announced today the pricing of its initial public offering of 9,000,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by ConforMIS. In addition, ConforMIS has granted the underwriters an option to…

    Read more »
  • Friday, 4/17/15

    ConforMIS Announces Settlement of Patent Infringement Lawsuits

    ConforMIS customized knee replacement

    Licenses Expand the Footprint of ConforMIS’ Patented Patient-Specific Instrumentation Technology Bedford, Mass. – April 17, 2015 – ConforMIS, Inc., a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture and sell customized joint replacement implants, today announced that it has entered into license agreements with each of Wright Medical Technology, Inc. (“Wright”) and…

    Read more »
  • Tuesday, 3/24/15

    ConforMIS Announces Latest Generation iTotal Customized Total Knee Replacement Implant System

    ConforMIS customized knee replacement

    Upgrades include improvements to customized implants and iJig patient-specific instruments Bedford, Mass. – March 24, 2015 – ConforMIS, Inc., a medical technology company providing customized total knee replacement implants for patients, today announced a new generation of the company’s iTotal® CR (cruciate-retaining) total knee replacement. The new generation iTotal CR was designed to improve procedural efficiency by further…

    Read more »
  • Tuesday, 1/6/15

    ConforMIS to Present at J.P. Morgan 33rd Annual Healthcare Conference

    ConforMIS customized knee replacement

    Bedford, Mass. – January 5, 2015 – ConforMIS, Inc., a medical device company providing the only truly customized knee replacement implant systems, today announced Philipp Lang, MD, MBA, Chairman and CEO of ConforMIS, will present at the 33rd Annual J.P. Morgan Healthcare Conference. Dr. Lang will highlight advantages of customized implants to patients, surgeons, hospitals and payers beginning…

    Read more »